Register Now

Login

Lost Password

Lost your password? Please enter your email address. You will receive a link and will create a new password via email.

Add post

You must login to add post .

Login

Register Now

Welcome to Scholarsark.com! Your registration will grant you access to using more features of this platform. You can ask questions, make contributions or provide answers, view profiles of other users and lots more. Register now!

Dark-roast coffee may prevent Alzheimer’s and Parkinson’s diseases

For years, scientists have suspected that drinking dark-roast coffee helps lessen the chances of getting Alzheimer’s and Parkinson’s diseases. A new study indicates that this may indeed be the case, and that the darker the roast, the better it works.

The longer a coffee is roasted, the higher its level of phenylindanes(Credit:AlekseyPatsyuk/Depositphotos)

Led by Dr. Donald Weaver, scientists at Canada’s Krembil Brain Institute compared three types of Starbucks 100-percent Arabica instant coffee – light roast, dark roast, and decaffeinated dark roast.

In in vitro (glass dish) tests, it was found that the two dark roasts were both particularly effective at keeping the protein fragments beta amyloid and tau from clumping. The clumping of these fragments within the brain is believed to be a key cause of both Alzheimer’s and Parkinson’s.

Of all the compounds that were analyzed in the coffees tested, there was only one – a group known as phenylindanes – that had the anti-clumping effect. The longer a coffee is roasted, the greater the amount of phenylindanes it contains, thus the more potent the effect is. Interestingly, the caffeinated and decaffeinated dark roasts were equally potent, indicating that caffeine content is irrelevant (that said, a study recently conducted at Indiana University Bloomington suggests that caffeine iseffective at warding off dementia).

“It’s the first time anybody’s investigated how phenylindanes interact with the proteins that are responsible for Alzheimer’s and Parkinson’s,” says Dr. Ross Mancini, who (along with biologist Yanfei Wang) assisted Weaver in the research. “The next step would be to investigate how beneficial these compounds are, and whether they have the ability to enter the bloodstream, or cross the blood-brain barrier.”


Source: newatlas.com, by Ben Coxworth

About Marie

Leave a reply

Brilliantly Safe & Student-Centered Learning Platform 2021